- Home
- INFU vs ACHV Comparison
INFU vs ACHV Comparison
Compare INFU & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INFU
- ACHV
- Stock Information
- Founded
- INFU 2005
- ACHV N/A
- Country
- INFU United States
- ACHV United States
- Employees
- INFU N/A
- ACHV N/A
- Industry
- INFU Medical/Dental Instruments
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- INFU Health Care
- ACHV Health Care
- Exchange
- INFU Nasdaq
- ACHV Nasdaq
- Market Cap
- INFU 180.4M
- ACHV 167.6M
- IPO Year
- INFU N/A
- ACHV N/A
- Fundamental
- Price
- INFU $10.36
- ACHV $5.12
- Analyst Decision
- INFU Strong Buy
- ACHV Strong Buy
- Analyst Count
- INFU 2
- ACHV 1
- Target Price
- INFU $13.50
- ACHV $12.00
- AVG Volume (30 Days)
- INFU 185.4K
- ACHV 2.4M
- Earning Date
- INFU 11-04-2025
- ACHV 11-06-2025
- Dividend Yield
- INFU N/A
- ACHV N/A
- EPS Growth
- INFU 2168.02
- ACHV N/A
- EPS
- INFU 0.24
- ACHV N/A
- Revenue
- INFU $139,886,000.00
- ACHV N/A
- Revenue This Year
- INFU $9.02
- ACHV N/A
- Revenue Next Year
- INFU $6.73
- ACHV N/A
- P/E Ratio
- INFU $43.65
- ACHV N/A
- Revenue Growth
- INFU 8.13
- ACHV N/A
- 52 Week Low
- INFU $4.61
- ACHV $1.84
- 52 Week High
- INFU $11.04
- ACHV $5.78
- Technical
- Relative Strength Index (RSI)
- INFU 57.28
- ACHV 70.28
- Support Level
- INFU $9.96
- ACHV $4.65
- Resistance Level
- INFU $10.87
- ACHV $5.07
- Average True Range (ATR)
- INFU 0.44
- ACHV 0.41
- MACD
- INFU 0.07
- ACHV 0.08
- Stochastic Oscillator
- INFU 73.44
- ACHV 76.00
About INFU InfuSystems Holdings Inc.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-reportable segment. The first is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second, Device Solutions, supports the Patient Services platform and leverages service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Majority from Patient.
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.